Log In
Print
BCIQ
Print
Print this Print this
 

UX007

  Manage Alerts
Collapse Summary General Information
Company Ultragenyx Pharmaceutical Inc.
DescriptionSynthetic compound that provides medium-length, odd-chain fatty acids that are metabolized to replace intermediate compounds of the tricarboxylic acid cycle
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationMitochondrial disease
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today